Nanalysis Scientific Corp.
NSCIF
$0.11
$0.0112.66%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.66M | 6.74M | 6.92M | 7.38M | 8.78M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.66M | 6.74M | 6.92M | 7.38M | 8.78M |
| Cost of Revenue | 5.58M | 5.27M | 5.24M | 5.49M | 5.79M |
| Gross Profit | 2.08M | 1.47M | 1.68M | 1.89M | 2.99M |
| SG&A Expenses | 1.44M | 1.66M | 2.20M | 1.94M | 1.90M |
| Depreciation & Amortization | 367.30K | 602.60K | 713.40K | 598.50K | 775.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.43M | 7.59M | 8.25M | 8.12M | 8.54M |
| Operating Income | 223.80K | -850.90K | -1.33M | -742.10K | 239.30K |
| Income Before Tax | -534.40K | -1.08M | -1.56M | -873.80K | -5.34M |
| Income Tax Expenses | -11.50K | 11.60K | -24.60K | 36.90K | -19.30K |
| Earnings from Continuing Operations | -522.90K | -1.09M | -1.53M | -910.70K | -5.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -522.90K | -1.09M | -1.53M | -910.70K | -5.32M |
| EBIT | 223.80K | -850.90K | -1.33M | -742.10K | 239.30K |
| EBITDA | 332.80K | -753.60K | -1.19M | -622.20K | 421.50K |
| EPS Basic | 0.00 | -0.01 | -0.01 | -0.01 | -0.05 |
| Normalized Basic EPS | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.05 |
| Normalized Diluted EPS | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 117.22M | 114.82M | 113.54M | 113.22M | 113.13M |
| Average Diluted Shares Outstanding | 117.22M | 114.82M | 113.54M | 113.22M | 113.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |